How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention

Ingrid Young, Lisa McDaid

Research output: Contribution to journalArticlepeer-review

Abstract

Recent research has demonstrated how antiretrovirals (ARVs) could be effective in the prevention of sexually transmitted HIV. We review research on the acceptability of oral pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) for HIV prevention amongst potential users. We consider with whom, where and in what context this research has been conducted, how acceptability has been approached, and what research gaps remain. Findings from 33 studies show a lack of TasP research, PrEP studies which have focused largely on men who have sex with men (MSM) in a US context, and varied measures of acceptability. In order to identify when, where and for whom PrEP and TasP would be most appropriate and effective, research is needed in five areas: acceptability of TasP to people living with HIV; motivation for PrEP use and adherence; current perceptions and management of risk; the impact of broader social and structural factors; and consistent definition and operationalisation of acceptability which moves beyond adherence.

Original languageEnglish
Pages (from-to)195-216
Number of pages22
JournalAIDS and Behavior
Volume18
Issue number2
DOIs
Publication statusPublished - 30 Jul 2013

Keywords

  • Adult
  • Anti-Retroviral Agents
  • Female
  • HIV Infections
  • Humans
  • Male
  • Patient Acceptance of Health Care
  • Sexual Behavior

Fingerprint

Dive into the research topics of 'How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention'. Together they form a unique fingerprint.

Cite this